
    
      Up to 50 consecutive participants with de-novo non-complex obstructive coronary lesions and
      non-ST elevation acute coronay syndromes or stable angina pectoris will be included in the
      Netherlands and Belgium.

      Device performance and behaviour will be assessed by angiography and optical coherence
      tomography at the index procedure and at 13 months follow-up.
    
  